TRAF1-ALK Fusion Predicts Poor Prognosis for ALK Positive Anaplastic Large Cell Lymphoma Patients with Chemotherapy and ALK Inhibitor

被引：1
|
作者：
Huang, Ling [1 ]
Jiang, Xinmiao [1 ]
Guo, Hanguo [1 ]
Liu Sichu [1 ]
Wei, Xiaojuan [1 ]
Chen Feili [1 ]
Liang, Zhanli [1 ]
Li, Wenyu [1 ]
机构：
[1] Guangdong Acad Med Sci, Lymphoma Div, Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-126541
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5224
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Anaplastic Large Cell Lymphomas: ALK Positive, ALK Negative, and Primary Cutaneous
    Xing, Xiaoming
    Feldman, Andrew L.
    ADVANCES IN ANATOMIC PATHOLOGY, 2015, 22 (01) : 29 - 49
  • [22] T- and B-cell response to the anaplastic lymphoma kinase (ALK) protein in patients with ALK-positive anaplastic large cell lymphoma (ALCL).
    Ait-Tahar, K
    Hatton, CSR
    Banham, AH
    Roberton, H
    Pulford, K
    BLOOD, 2003, 102 (11) : 897A - 898A
  • [23] Combination of crizotinib and chemotherapy in patients with relapsed or refractory anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL)
    Chen, Mei-ting
    Fu, Xiao-hong
    Huang, He
    Wang, Zhao
    Fang, Xiao-jie
    Yao, Yu-Yi
    Ren, Quan-Guang
    Chen, Ze-geng
    Lin, Tong-yu
    LEUKEMIA & LYMPHOMA, 2021, 62 (03) : 571 - 580
  • [24] The NPM/ALK gene fusion in the pathogenesis of anaplastic large cell lymphoma
    Ladanyi, M
    CANCER SURVEYS, 1997, 30 : 59 - 75
  • [25] The Association between the Percentage of Anaplastic Lymphoma Kinase(ALK)-Positive Cells and Efficacy of ALK Inhibitor
    Tanaka, Tae
    Yoshioka, Hiroshige
    Haratani, Koji
    Hayashi, Hidetoshi
    Okamoto, Kunio
    Kaneda, Toshihiko
    Yokoyama, Toshihide
    Takeda, Masayuki
    Kaneda, Hiroyasu
    Nakagawa, Kazuhiko
    Ishida, Tadashi
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1162 - S1162
  • [26] ALK-positive desmoplastic Spitz naevus in a patient with corresponding ALK-positive anaplastic large cell lymphoma
    Nguyen, J.
    Huang, A.
    Fleming, J.
    MacGregor, D.
    Wilks, D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S13 - S13
  • [27] A Case of Colonic ALK-Positive Anaplastic Large Cell Lymphoma
    Petropolis, Harrison
    Arseneau, Iain
    Blackman, Rachelle
    Fraser, Hughie
    Epstein, Ian
    Anderson, David
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S860 - S861
  • [28] Arsenic trioxide degrades NPM-ALK fusion protein and inhibits growth of ALK-positive anaplastic large cell lymphoma
    W Piao
    D Chau
    L M Yue
    Y-L Kwong
    E Tse
    Leukemia, 2017, 31 : 522 - 526
  • [29] Leukemic phase of ALK-positive anaplastic large cell lymphoma
    He, Rong
    Viswanatha, David S.
    BLOOD, 2013, 121 (11) : 1934 - 1934
  • [30] ALK positive lymphohistiocytic variant of anaplastic large cell lymphoma in an adult
    Paulli, M
    Vallisa, D
    Viglio, A
    Boveri, E
    Kindl, S
    Vassallo, G
    Magrini, U
    Cavanna, L
    HAEMATOLOGICA, 2001, 86 (03) : 260 - 265
12345